• 文章类型: Journal Article
    背景:总结基于“5S”目标的“九步法”乳腔镜下乳房皮下切除术的经验,并规范该操作。
    方法:在2002年1月1日至2021年10月31日之间,共1082名男性乳房发育症患者的2035个乳房,其中129名患者一侧,均接受乳腔镜皮下乳房切除术。随访终点为术后3个月。
    结果:所有患者均顺利完成手术,他们都没有被转移到露天手术。单侧乳房的手术时间为12-28分钟,平均时间为17.7±6.2min。单侧手术过程中出血量很少,大约5-10毫升。术后引流总量为5~50ml,在3-5天内拔除引流管。0.3%乳头发生表皮坏死。0.2%的胸壁在乳房的超内侧区域有一点瘀斑。所有患者的乳头和乳晕感觉正常,平滑和对称的胸壁,和自然的轮廓。随访期间无复发。
    结论:基于“5S”目标的“九步法”乳腔镜皮下乳房切除术治疗男性乳房发育症手术时间短,手术并发症少,美学效果好。它实现了“5S”目标,完全去除腺体组织(清扫),小的和疤痕隐藏的切口小(无疤痕),双侧胸壁良好的对称性(对称性),正常的胸部形状(形状),和平滑胸壁(平滑)。
    方法:该杂志要求作者为每篇文章指定一个级别的证据。有关循证医学评级的完整描述,请参阅www上的目录或在线作者说明。springer.com/00266.
    BACKGROUND: To summarize the experiences on the mastoscopic subcutaneous mastectomy for gynecomastia by \"nine-step method\" based on the \"5S\" goal and standardize this operation.
    METHODS: Between January 1, 2002, and October 31, 2021, a total of 2035 breasts of 1082 male patients with gynecomastia, of which 129 patients with one side, were underwent mastoscopic subcutaneous mastectomy. The follow-up endpoint was 3 months after surgery.
    RESULTS: All patients were successfully completed the operation, and none of them was transferred to open operation. The operation time for unilateral breast was 12-28 min, and the average time was 17.7 ± 6.2 min. The amount of bleeding during unilateral operation was very small, about 5-10 ml. The total drainage volume was 5-50 ml after the operation, and the drainage tube was removed in 3-5 days. The epidermal necrosis occurred in 0.3% nipple. 0.2% chest wall had a little ecchymosis in the supero-medial region of the breast. All patients had the normal feeling of nipples and areola, the smoothing and symmetrical chest wall, and the natural contour. There was no recurrence during the follow-up period.
    CONCLUSIONS: The mastoscopic subcutaneous mastectomy for gynecomastia by \"nine-step method\" based on the \"5S\" goal has a short operation time, few surgical complications and good esthetics. It achieves the \"5S\" goals on the complete removal of glandular tissue (sweeping), small and scar-hidden incision are small (scarless), good symmetry of bilateral chest wall (symmetry), normal chest shape (shape), and smoothing chest wall (smoothing).
    METHODS: The journal asks authors to assign a level of evidence to each article. For a complete description of Evidence-Based Medicine ratings, see the Table of Contents or the online Instructions for Authors at www.springer.com/00266 .
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Case Reports
    乳腺癌是全球癌症的主要原因之一。保乳手术后的放射治疗是乳腺癌的标准治疗方法。最近,选择16个部分中包含42.56Gy的大分割照射作为可行的放射治疗选择.放射性肉瘤是乳腺癌手术后接受放疗的患者中最常见的继发性恶性肿瘤。血管肉瘤是放射诱导肉瘤的主要类型,而脂肪肉瘤很少被报道。本报告详细介绍了在保乳手术和大分割放疗后8年发生的辐射诱导的多形性脂肪肉瘤的罕见情况。由于右乳房皮肤下的组织硬化,患者去了医院。超声检查显示右乳房下部有低回声肿块,包含内部血流。切除活检显示,肿瘤包含浸润性梭形细胞,没有包含多形性细胞的胶囊。也观察到成纤维细胞,并倾向于分化为脂肪组织,导致多形性脂肪肉瘤的诊断。免疫染色显示细胞角蛋白AE1/AE3,ERG,MDM2和S-100蛋白;Ki-67指数为~20%。由于肿瘤边缘紧密,进行了涉及术后床的扩大切除术。18F-氟代脱氧葡萄糖正电子发射体层摄影术/计算机断层扫描显示18F-氟代脱氧葡萄糖在右胸壁的苍白积累,这被解释为由于切除活检而导致的术后变化。在照射区域观察到肿瘤,没有远处转移。广泛切除后,患者维持3年零2个月的无复发生存期,在此期间没有给予辅助治疗。因此,对接受放疗的乳腺癌患者进行随访是必要的.
    Breast cancer is one of the leading causes of cancer globally. Radiotherapy following breast-conserving surgery is the standard treatment of breast cancer. Recently, hypofractionated irradiation comprising 42.56 Gy in 16 fractions was selected as a viable radiation therapeutic option. Radiation-induced sarcoma is the most prevalent secondary malignancy in patients undergoing radiotherapy after breast cancer surgery. Angiosarcomas are the predominant type of radiation-induced sarcomas, whereas liposarcomas have rarely been reported. The present report details an uncommon instance of radiation-induced pleomorphic liposarcoma that occurred 8 years after breast-conserving surgery and hypofractionated radiotherapy. The patient visited the hospital due to hardening of the tissue beneath the skin of the right breast. Ultrasonography revealed a hypoechoic mass in the lower part of the right breast containing internal blood flow. An excisional biopsy revealed that the tumor contained infiltrating spindle-shaped cells without a capsule containing pleomorphic cells. Lipoblasts were also observed and tended to differentiate into adipose tissue, leading to a diagnosis of pleomorphic liposarcoma. Immunostaining revealed negativity for cytokeratin AE1/AE3, ERG, MDM2 and S-100 protein; the Ki-67 index was ~20%. An enlargement resection involving a postoperative bed was performed because of close tumor margins. 18F-fluorodeoxyglucose positron emission tomography/computed tomography revealed pale accumulation of 18F-fluorodeoxyglucose in the right chest wall, which was interpreted as a postoperative change owing to the resection biopsy. The tumor was observed in the irradiated field with no distant metastases. Following extensive resection, the patient maintained a recurrence-free survival period of 3 years and 2 months, during which no adjuvant therapy was administered. Therefore, follow-up is necessary in patients with breast cancer treated with radiotherapy.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    我们介绍一例原发性血管肉瘤,极为罕见的恶性乳腺病变,一名21岁女性患者单侧乳房增大。原发性血管肉瘤是乳腺癌的一种侵袭性形式,由于该疾病的稀有性,其表现可变,临床经验有限。尽管最初的诊断挑战,本报告展示了在年轻患者中罕见乳腺病变的背景下,系统诊断方法和多学科管理的重要性.我们的病人接受了乳房切除术,然后进行了乳房重建,实现良好的美容效果。此病例有助于我们了解年轻患者乳腺血管肉瘤的诊断考虑因素。
    We present a case of primary angiosarcoma, an exceedingly rare malignant breast lesion, in a 21-year-old female patient with unilateral breast enlargement. Primary angiosarcoma is an aggressive form of breast cancer with variable presentation and limited clinical experience due to the rarity of the disease. Despite an initial diagnostic challenge, this report showcases the importance of a systematic diagnostic approach and multidisciplinary management in the context of uncommon breast lesions in young patients. Our patient underwent a mastectomy followed by breast reconstruction, achieving favourable cosmetic outcomes. This case serves as a contribution to our understanding of the diagnostic considerations surrounding angiosarcoma of the breast in a young patient.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    已知PALB2中的遗传种系突变会使患者患乳腺癌的风险更高,到80岁时,超过一半的受影响女性患乳腺癌的风险估计为卵巢癌和胰腺癌。目前筛查PALB2突变患者的指南包括从30岁开始的年度乳房X光检查,并考虑乳房磁共振成像(MRI)和断层合成。关于乳房切除术降低风险的现有证据不足以为患者提供明确的建议。在这个系列中,我们描述了5例伴PALB2突变的单侧乳腺癌患者的表现和治疗.据我们所知,这是首次报道的病例系列,讨论了对侧降低风险乳房切除术(CRRM)在PALB2突变乳腺癌患者中的作用.我们研究的目的是通过现实世界的临床病例和文献综述来评估PALB2致病性变异患者在管理乳腺癌风险方面的挑战。
    在这项回顾性观察研究中,我们介绍了5例年龄在29~61岁之间的PALB2突变患者,他们在2020年11月至2022年3月期间被诊断为乳腺癌并在我们机构接受了乳腺癌手术治疗.通过他们的临床课程和文献综述,我们讨论了CRRM在PALB2基因突变的乳腺癌患者中的作用。
    在5名患者中,3例患者接受CRRM,2例患者选择单侧手术治疗乳腺癌,并积极监测对侧乳腺。在接受CRRM的3名患者中,1例患者经历了预防侧重建的手术并发症。没有患者出现任何复发,平均随访时间为15.4个月。
    根据我们的经验和现有文献,PALB2突变患者的CRRM应通过考虑总体风险的共同决策过程逐案进行。家族史,患者偏好和生活质量。
    UNASSIGNED: Inherited germline mutations in PALB2 are known to predispose patients to a higher risk of breast, ovarian and pancreatic cancer with an estimated risk of developing breast cancer in over half of all affected women by age 80 years. Current guidelines for screening patients with PALB2 mutations include annual mammograms beginning at age 30 years and consideration of breast magnetic resonance imaging (MRI) and tomosynthesis. Existing evidence regarding risk-reducing surgery with mastectomy is insufficient to make a definitive recommendation to patients. In this case series, we describe the presentation and management of 5 patients with unilateral breast cancer and PALB2 mutations. To our knowledge, this is the first reported case series discussing the role of contralateral risk-reducing mastectomy (CRRM) in breast cancer patients with PALB2 mutations. The aim of our study was to evaluate the challenges in managing breast cancer risk in patients with PALB2 pathogenic variants with illustration through real-world clinical cases and a review of the literature.
    UNASSIGNED: In this retrospective observational study, we present 5 patients with PALB2 mutations between the ages of 29 and 61 years who were diagnosed with breast cancer and underwent surgical management of their breast cancer at our institution between November 2020 and March 2022. Through their clinical courses and a literature review, we discuss the role of CRRM in breast cancer patients with PALB2 gene mutations.
    UNASSIGNED: Out of the 5 patients, 3 patients underwent CRRM and 2 patients chose unilateral surgery for their breast cancer and active surveillance for the contralateral breast. Of the 3 patients who underwent CRRM, 1 patient experienced a surgical complication from reconstruction on the prophylactic side. None of the patients developed any recurrences with an average length of follow up of 15.4 months.
    UNASSIGNED: Based on our experience and the currently available literature, CRRM in patients with a PALB2 mutation should be performed on a case-by-case basis through a shared decision-making process taking into consideration overall risk, family history, patient preference and quality of life.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    假血管瘤性间质增生(PASH)是一种少见的间叶性良性乳腺肿瘤。PASH可能在绝经前妇女中表现为快速增长的肿块。重要的是排除乳腺肿块的其他原因,包括纤维腺瘤,错构瘤,叶状肿瘤和浸润性腺癌。据我们所知,这是英语文献中最大的PASH肿瘤病例,也是第一个通过乳房切除术和立即乳房植入物重建进行治疗的病例。
    一名45岁女性,有双侧隆胸手术史,无其他合并症,2020年12月13日,她的左右乳房之间出现了严重的不对称。她抱怨疼痛和衣服的明显差异。她接受了三重评估(历史和检查,成像,和活检)。双侧乳房X线照片显示右乳房可能有肿块。在超声成像上,有证据表明存在广泛的不明确的低回声变化。从肿块中取出核心活检和真空辅助核心活检,并于2021年1月12日作为PASH/纤维囊性改变返回。讨论了手术选择,经过一番考虑,她决定在2021年3月15日进行乳房切除术和立即植入物重建。她于2021年9月9日接受了手术,标本重量为1.911kg,尺寸为27cm×22.6cm×7.4cm,这是最大的PASH肿瘤。她恢复得很简单,4周后在诊所就诊,并对美容结果感到满意。PASH可以在活检中作为偶然的显微病灶出现,以弥漫性增大乳房。PASH没有特定的放射学或诊断功能,因此根据组织学诊断。PASH与恶性肿瘤风险增加无关,管理取决于表现。当偶然发现PASH或无症状时,可以进行连续乳房X光检查以评估生长情况。如果三重评估或不适等症状有任何可疑特征或不一致,则应进行手术切除。
    PASH应被视为快速乳房增大的鉴别诊断的一部分。应尽早与患者讨论治疗方案,以防止进展。对于快速丰胸,应考虑乳房切除术和立即重建,并与患者讨论。
    UNASSIGNED: Pseudoangiomatous stromal hyperplasia (PASH) is an uncommon mesenchymal benign breast neoplasm. PASH may present as a rapidly growing mass in pre-menopausal women. It is important to rule out other causes of a breast lump including fibroadenoma, hamartoma, phyllodes tumour and invasive adenocarcinoma. To our knowledge this is the largest case of PASH tumour in the English literature and the first to be managed with mastectomy and immediate breast implant reconstruction.
    UNASSIGNED: A 45-year-old woman with a history of bilateral breast augmentation for cosmesis and no other co-morbidities, presented with gross asymmetry between her right and left breasts on 13th December 2020. She complained about pain and the noticeable difference in clothing. She underwent triple assessment (history and examination, imaging, and biopsy). Bilateral mammograms showed the right breast had a possible mass. On ultrasound imaging there was evidence of extensive ill-defined hypoechoic changes. Core biopsies and a vacuum assisted core biopsy were taken from the mass and came back as PASH/fibrocystic change on 12th January 2021. Surgical options were discussed, and after some consideration she decided on mastectomy and immediate implant reconstruction on 15th March 2021. She underwent the operation on 9th September 2021 and the specimen weight was 1.911 kg and measured 27 cm × 22.6 cm × 7.4 cm which is the largest reported PASH tumour. She made an uncomplicated recovery and was seen in clinic 4 weeks later and was happy with the cosmetic outcome. PASH can present as incidental microscopic foci in biopsies to diffuse enlargement of the breast. PASH has no specific radiological or diagnostic features, therefore is diagnosed based on histology. PASH is not associated with an increased risk of malignancy and the management is dependent on the presentation. When PASH is discovered incidentally or is asymptomatic it can be followed up with serial mammography to assess growth. If there are any suspicious features or discordance following triple assessment or symptoms such as discomfort surgical excision is indicated.
    UNASSIGNED: PASH should be considered as part of the differential diagnosis for rapid breast enlargement. Treatment options should be discussed early with the patient to prevent progression. For rapid breast enlargement mastectomy and immediate reconstruction should be considered and discussed with the patient.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    通常选择浅上腹下动脉(SIEA)皮瓣以最大程度地减少术后并发症,例如腹痛和膨出。然而,缺点,包括小直径和短椎弓根,在吻合或创建乳房下极方面构成挑战。这里,我们报告了一例使用SIEA皮瓣通过动静脉环(AV-loop)通过对侧浅上腹下静脉(SIEV)移植物进行椎弓根延长的乳房重建病例。一名49岁的妇女接受了左全乳房切除术,主要插入了组织扩张器。计划使用带有椎弓根延长的SIEA皮瓣进行乳房重建。运行模式,椎弓根长度,术前使用48MHz超高频超声探头(VevoMD超声设备,富士胶片视觉超音速仪,阿姆斯特丹,荷兰)。在皮瓣收获期间,收获对侧SIEV移植物以产生用于椎弓根伸长的AV环。将9cm移植物与左乳内动脉和静脉(IMA/IMV)吻合。襟翼抬高后,创建的AV-loop在中点分开并吻合到SIEA皮瓣的蒂。SIEA皮瓣,用SIEVAV环路扩展,促进了乳房下极的增大,而没有椎弓根扭结和拉扯的风险。术后进展顺利,患者在术后第7天出院。通过AV环延长的椎弓根长度可防止椎弓根扭结,并允许更自由地定位皮瓣,通过填充下极,从而获得美学上良好的乳房轮廓。使用超高频超声对血管进行精确的术前评估有助于精心计划。如果外科医生旨在最大程度地减少与其他腹部游离皮瓣相关的术中和术后并发症,这种方法可能被认为是一个可行和有希望的选择。
    Superficial inferior epigastric artery (SIEA) flap is often chosen to minimize postoperative complications such as abdominal pain and bulging. However, drawbacks, including a small diameter and a short pedicle, pose challenges in anastomosing or creating the lower pole of the breast. Here, we report a case of breast reconstruction using an SIEA flap with pedicle elongation via an arteriovenous loop (AV-loop) using a contralateral superficial inferior epigastric vein (SIEV) graft. A 49-year-old woman underwent a left total mastectomy with the primary insertion of a tissue expander. Breast reconstruction using an SIEA flap with pedicle elongation was planned. The running pattern, pedicle length, and diameter of bilateral SIEA/SIEV and superficial circumflex iliac artery and vein (SCIA/SCIV) were evaluated preoperatively using a 48-MHz probe of ultra-high-frequency ultrasonography (Vevo MD ultrasound device, Fujifilm Visual Sonics, Amsterdam, the Netherlands). During the flap harvesting, the contralateral SIEV graft was harvested to create an AV-loop for pedicle elongation. The 9 cm graft was anastomosed to the left internal mammary artery and vein (IMA/IMV). After the flap elevation, the created AV-loop was divided at the midpoint and anastomosed to the pedicle of the SIEA flap. The SIEA flap, extended with a SIEV AV-loop, facilitated the augmentation of the lower pole of the breast without the risk of pedicle kinking and pulling. The postoperative course was uneventful, and the patient was discharged on postoperative day 7. The prolonged pedicle length via an AV-loop prevents the pedicle kinking and allows for positioning the flap more freely, resulting in an aesthetically good breast contour by filling in the lower pole. The precise preoperative evaluation of the vessels using ultra-high-frequency ultrasonography facilitated meticulous planning. In cases where surgeons aim to minimize intraoperative and postoperative complications associated with other abdominal free flaps, this method may be considered a viable and promising option.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Case Reports
    卡尼复合体是一种罕见的常染色体显性遗传的常见多发性瘤形成综合征,并伴有心血管表现。我们的报告描述了一个卡尼复杂病例,伴有双侧粘液样纤维腺瘤,导致双侧乳房切除术。一名18岁的女性患者在我们的诊所就诊,抱怨她的双侧乳房有多个明显的肿块。在体格检查中,患者脸上也有多个色素性浅色病变,身体和她的巩膜,蓝色的痣在她的躯干和上肢和一个圆形的月亮形的脸。卡尼综合征的诊断取决于影像学,活检和遗传分析。患者接受了双侧乳房切除术作为预防性治疗计划,并放置了组织扩张器。由Carney复合体引起的乳腺粘液瘤病是女性患者的常见特征。在这些情况下,预防性乳房切除术必须被视为一种治疗干预措施,因为它提供了明确的治疗方法。副作用最小,结果极好。
    Carney complex is a rare autosomal dominant familiar multiple neoplasia syndrome combined with cardiocutaneous manifestations. Our report describes a Carney complex case with bilateral myxoid fibroadenomas that led to a bilateral mastectomy. An 18-year-old female patient presented at our clinic with complaints of multiple palpable lumps in her breasts bilaterally. On physical examination the patient had also multiple pigmented lentiginous lesions on her face, body and her sclerae, blue nevi on her trunk and upper extremities and a round moon-shaped face. The diagnosis of Carney syndrome was decided upon imaging, biopsies and genetic analysis. The patient underwent a bilateral mastectomy as a prophylactic treatment plan with tissue expanders\' placement. Breast myxomatosis due to Carney complex is a common characteristic in female patients. Prophylactic mastectomy must be considered as a therapeutic intervention in these cases since it provides a definite treatment, with minimal side effects and excellent outcomes.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    对于早期乳腺癌患者,保乳手术(BCS)是一种公认的标准治疗选择,可替代乳房切除术,包括乳房切除术,然后进行辅助放疗。然而,当需要进行治疗后手术管理时,受照射的组织伤口愈合并发症的风险增加.辐照伤口裂开的处理可能具有挑战性,因为与传统的手术伤口裂开相比,它通常需要多模式治疗方法,包括更多的侵入性干预措施。我们介绍了一位64岁的女性患者,在12年前接受了早期乳腺癌的放射治疗,由于同侧乳腺癌复发,他最近需要进行简单的乳房切除术。术后过程因乳房切除术伤口的开裂而变得复杂。标准伤口护理治疗失败后,用合成电纺纤维基质治疗后,她的手术伤口成功愈合。患有其他合并症的患者通常不符合侵入性重建选择的资格;因此,有效的本地管理选择是必要的。这是第一个报道的病例,记录了合成电纺纤维基质在先前照射过的纤维化区域内愈合裂开的手术伤口的功效和安全性。无需进一步的侵入性手术干预。更大规模的研究,如前瞻性队列研究或随机对照试验,需要研究其在辐照伤口中的新用途。
    Breast-conserving surgery (BCS) is a well-established standard treatment option alternative to mastectomy for patients with early breast cancer that consists of a lumpectomy followed by adjuvant radiotherapy. However, irradiated tissues are at an increased risk of wound healing complications when post-treatment surgical management is required. The management of an irradiated wound dehiscence can be challenging, as it often requires a multimodal treatment approach that includes more invasive interventions when compared to a traditional surgical wound dehiscence. We present a 64 year old female patient with a remote history of right BCS with radiation therapy for early breast cancer 12 years ago, who recently required a simple mastectomy due to ipsilateral breast cancer recurrence. The post-operative course was complicated by dehiscence of the mastectomy wound. After standard wound care therapies failed, her surgical wound successfully healed after treatment with a synthetic electrospun fiber matrix application. Patients with additional comorbidities often do not qualify for invasive reconstructive options; therefore, effective local management options are warranted. This is the first reported case documenting synthetic electrospun fiber matrix efficacy and safety in healing a dehisced surgical wound within a previously irradiated fibrotic area, without the need for further invasive surgical intervention. Larger scale research, such as a prospective cohort study or randomized control trial, is needed to investigate its novel use in irradiated wounds.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    乳房切除术是狗中常见且痛苦的程序。伤口浸泡导管(WSC)经常用于减轻术后疼痛,包括乳房切除术后的疼痛.本病例系列的目的是描述WSC在手术治疗的乳腺肿瘤犬术后局部镇痛的所有者管理中的用途,确定与WSC相关的并发症并确定导管细菌定植的频率。在乳房切除术期间,12只WSC被放置在11只狗中,留在原地三天,由敷料保护,并由业主在家中成功管理。术后未使用抗生素。在任何情况下都没有发现并发症。在12个WSC的细菌学分析中没有鉴定出细菌生长。这些结果表明,使用WSC是狗乳房切除术后术后镇痛的安全选择。未来的研究需要将有或没有WSC的狗与更多数量的狗进行比较,以进一步评估疗效和并发症。
    Mastectomy is a common and painful procedure in dogs. Wound soaker catheters (WSC) are frequently used to reduce postoperative pain, including pain after mastectomy. The objectives of this case series were to describe the use of WSC for owner administration of postoperative local analgesia in dogs with mammary tumors treated surgically, to identify complications associated with WSC and to determine the frequency of bacterial colonization of the catheters. Twelve WSC were placed in 11 dogs during mastectomy surgery, left in place for three days, protected by a dressing and successfully managed by owners at home. No postoperative antibiotics were administered. No complications were identified in any cases. No bacterial growth was identified on bacteriological analysis of the twelve WSC. These results suggest that the use of WSC is a safe alternative for postoperative analgesia administration following mastectomy in dogs. Future studies comparing dogs with or without WSC with a larger number of dogs are needed to further evaluate efficacy and complications.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • DOI:
    文章类型: Case Reports
    我们报告了一名66岁女性的右晚期乳腺癌伴多发肺转移的病例。她的乳腺癌(浸润性导管癌,cT4bN1M1,Ⅳ期)在局部动脉灌注治疗(总剂量5-FU4,735mg加阿霉素180mg)后于2007年10月切除(乳房切除术加腋窝淋巴结清扫术),由于右腿深静脉血栓形成导致双侧肺动脉栓塞。她必须接受抗凝治疗,手术前机械通气和放置IVC过滤器。继续进行随后的化学内分泌治疗(多西他赛6个疗程加阿那曲唑)。2008年10月,CT扫描显示多发性肺转移瘤消失(完全缓解)。2015年11月(手术后8年),CT扫描显示多发肺转移复发,内分泌治疗改为他莫昔芬.一年后,CT扫描显示多发性肺转移灶再次消失(完全缓解),乳腺癌患者的病情一直保持到2023年5月(手术后15年).
    We report a case of right advanced breast cancer with multiple lung metastases in a 66-year-old woman. Her breast cancer( invasive ductal carcinoma, cT4bN1M1, Stage Ⅳ)was resected in October 2007(mastectomy plus axillary lymph node dissection)after local arterial infusion therapy(total dose 5-FU 4,735 mg plus adriamycin 180 mg), which caused bilateral lung arterial embolism due to deep vein thrombosis in right her leg. She had to be treated by anticoagulant therapy, mechanical ventilation and placement of IVC filter before her operation. Subsequent chemo-endocrine therapy(docetaxel 6 courses plus anastrozole)was continued. In October 2008, a CT scan showed disappearance of multiple lung metastases (complete response). In November 2015 (8 years after her operation), a CT scan showed recurrence of multiple lung metastases and endocrine therapy was changed to tamoxifen. A year later, a CT scan showed disappearance of multiple lung metastases(complete response)again and keep a condition of complete response in her breast cancer until May 2023 (15 years after her operation).
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号